Location: Dallas, TX
CIK: 0002043476 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $213M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | INVESCO QQQ TR | 50,000 | $36.82M | 17.3% | — | — | Put | 46090E953 |
| ADMA | ADMA BIOLOGICS INC | 3,262,542 | $27.31M | 12.8% | — | — | COM | 000899104 |
| PALI | PALISADE BIO INC | 11,414,285 | $23.86M | 11.2% | — | — | COM | 696389402 |
| NRXP | NRX PHARMACEUTICALS INC | 4,091,767 | $16.74M | 7.9% | — | — | COM NEW | 629444209 |
| SNSE | FAETH THERAPEUTICS INC | 610,169 | $15.25M | 7.2% | — | — | COM NEW | 81728A207 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,800,556 | $12.26M | 5.8% | — | — | COM SHS | 877619106 |
| PRAX | PRAXIS PRECISION MEDICINES I | 33,237 | $11.13M | 5.2% | — | — | COM NEW | 74006W207 |
| CLLS | CELLECTIS S A | 3,281,501 | $9.845M | 4.6% | — | — | SPON ADS | 15117K103 |
| ZLAB | ZAI LAB LTD | 450,646 | $8.562M | 4.0% | — | — | ADR | 98887Q104 |
| GPCR | STRUCTURE THERAPEUTICS INC | 140,000 | $7.514M | 3.5% | — | — | SPONSORED ADS | 86366E106 |
| ORKA | ORUKA THERAPEUTICS INC | 75,000 | $7.138M | 3.4% | — | — | COM | 687604108 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 1,500,000 | $6.24M | 2.9% | — | — | COM | 462260100 |
| SYRE | SPYRE THERAPEUTICS INC | 70,000 | $6.215M | 2.9% | — | — | COM NEW | 00773J202 |
| AURA | AURA BIOSCIENCES INC | 764,243 | $5.426M | 2.5% | — | — | COM | 05153U107 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 175,706 | $4.828M | 2.3% | — | — | COM NEW | 045396207 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 67,500 | $4.739M | 2.2% | — | — | COM NEW | 10919W405 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 135,000 | $4.508M | 2.1% | — | — | COM | 90400D108 |
| SGHT | SIGHT SCIENCES INC | 970,000 | $3.657M | 1.7% | — | — | COM | 82657M105 |
| FHTX | FOGHORN THERAPEUTICS INC | 200,000 | $976K | 0.5% | — | — | COM | 344174107 |